Insmed Inc Stock Investor Sentiment

INSM Stock  USD 22.00  1.60  6.78%   
About 63% of Insmed's investor base is looking to short. The analysis of the overall investor sentiment regarding Insmed Inc suggests that many traders are alarmed. Insmed's investor sentiment overview provides quick insight into current market opportunities from investing in Insmed Inc. The current market sentiment, together with Insmed's historical and current headlines, can help investors time the market. In addition, many technical investors use Insmed Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

37

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Insmed's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Insmed Inc.
Insmed stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Insmed daily returns and investor perception about the current price of Insmed Inc as well as its diversification or hedging effects on your existing portfolios.

Insmed Historical Sentiment

Although Insmed's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Insmed, such as negative comments on social media and news outlets, may cause fear in the market and push Insmed's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Insmed.
  

Insmed Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Insmed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Insmed Inc Historical Investor Sentiment

Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Insmed news discussions. The higher the estimate score, the more favorable the investor's outlook on Insmed.

Insmed Maximum Pain Price across 2024-06-21 Option Contracts

Insmed's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Insmed close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Insmed's options.
21 hours ago at news.google.com         
Relative Strength Alert For Insmed - Nasdaq
Google News at Macroaxis
a day ago at simplywall.st         
Have Insiders Sold Insmed Shares Recently?
Simply Wall St News at Macroaxis
3 days ago at benzinga.com         
Insmed Unusual Options Activity For May 21
benzinga news
few days ago at investing.com         
Insmed reports promising ARIKAYCE study results
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study O...
Yahoo News
six days ago at gurufocus.com         
Disposition of 5945 shares by Roger Adsett of Insmed at 25.09 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
six days ago at gurufocus.com         
Insider Sale Chief Medical Officer Martina Flammer Sells Shares of Insmed Inc
Gurufocus Stories at Macroaxis
over a week ago at investing.com         
Insmed executive sells over 270k in company stock
Investing News at Macroaxis
over a week ago at investing.com         
Acquisition by Lee Leo of 13162 shares of Insmed subject to Rule 16b-3
Investing News at Macroaxis
over a week ago at investing.com         
Insmed CFO sells over 280k in company stock
Investing News at Macroaxis
over a week ago at investing.com         
Insmed COO sells 200k in company stock
Investing News at Macroaxis
over a week ago at investing.com         
Insmed chief legal officer sells over 129k in company stock
Investing News at Macroaxis
over a week ago at investing.com         
Insmed CEO sells over 566k in company stock
Investing News at Macroaxis
over a week ago at investing.com         
Insmed executive sells over 129k in company stock
Investing News at Macroaxis
over a week ago at investing.com         
Insmed executive sells shares worth over 166k
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Insmed that are available to investors today. That information is available publicly through Insmed media outlets and privately through word of mouth or via Insmed internal channels. However, regardless of the origin, that massive amount of Insmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insmed alpha.

Insmed Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Seven Eight Capital LP Purchases Shares of 52,051 Insmed Incorporated - MarketBeat
03/07/2024
2
Insmed shares upgraded on growth potential
04/23/2024
3
Should You Buy Insmed Ahead of Earnings
05/08/2024
4
Insmed Q1 Earnings How Key Metrics Compare to Wall Street Estimates
05/09/2024
5
Insmed First Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
05/10/2024
6
Mizuho raises Insmed stock target on positive outlook
05/13/2024
7
Disposition of 7857 shares by Roger Adsett of Insmed at 25.5 subject to Rule 16b-3
05/14/2024
8
Insmed COO sells 200k in company stock
05/15/2024
9
Insmed reports promising ARIKAYCE study results
05/20/2024
10
Have Insiders Sold Insmed Shares Recently
05/23/2024
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Insmed Hype Analysis, Insmed Correlation and Insmed Performance.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.23)
Revenue Per Share
2.199
Quarterly Revenue Growth
0.158
Return On Assets
(0.32)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.